pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Metabolic Acidosis in 1 studies
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.
Excerpt | Relevance | Reference |
---|---|---|
" Dose-response curves were fit with nonlinear regression analysis to calculate the EC(50) and slope." | 1.33 | Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries. ( Buckwalter, JB; Clifford, PS; Hamann, JJ; Kluess, HA, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kluess, HA | 1 |
Buckwalter, JB | 1 |
Hamann, JJ | 1 |
Clifford, PS | 1 |
1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Metabolic Acidosis
Article | Year |
---|---|
Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries.
Topics: Acidosis; Adenosine Triphosphate; Animals; Arteries; Hydrogen-Ion Concentration; Male; Muscle, Skele | 2005 |